JP Morgan Downgrades Johnson & Johnson to “Neutral” on Valuation Call (JNJ)

JP Morgan analysts downgraded health care products maker Johnson & Johnson (JNJ) on Monday on a valuation call.

The analysts downgraded JNJ from “Overweight” to “Neutral” and see shares reaching $83. This target suggests a 1% upside to Friday’s closing price of $82.04.

Johnson & Johnson shares were down 50 cents, or -0.61%, during pre-market trading on Monday. The stock is up +17.03% year-to-date.

The Bottom Line
Shares of Johnson & Johnson (JNJ) have a dividend yield of 2.97% based on Friday’s closing price of $82.04 and the company’s annualized dividend payout of $2.44 per share.

Johnson & Johnson (JNJ) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here